Education
About Us
Working with TipRanks
Follow Us
Femasys (FEMY)
NASDAQ:FEMY
FEMY Stock Chart & Stats
$0.53
-$0.01(-0.91%)
At close: 4:00 PM EST
$0.53
-$0.01(-0.91%)
Day’s Range― - ―
52-Week Range$0.31 - $1.80
Previous CloseN/A
Volume25.00K
Average Volume (3M)5.88M
Market Cap
$26.34M
Enterprise Value$32.53M
Total Cash (Recent Filing)$3.22M
Total Debt (Recent Filing)$7.85M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Nov 06, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding43,009,995
10 Day Avg. Volume13,445,559
30 Day Avg. Volume5,876,814
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue17.24
Enterprise Value/Gross Profit32.10
Enterprise Value/Ebitda-1.77
Forecast
1Y Price Target
$5.50Price Target Upside937.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Regulatory ApprovalsFemaSeed and FemVue were granted regulatory approval in Australia and New Zealand, opening yet another market for revenue generation.
Strategic PartnershipsFemasys has secured a significant strategic partnership with Kebomed to commercialize its FemBloc across France and the Benelux region, marking a major step in its European growth strategy.
Bears Say
Revenue ProjectionsThe sales ramp is slower than anticipated, leading to a lower 2025 revenue estimate.
Femasys News
FEMY FAQ
What was Femasys’s price range in the past 12 months?
Femasys lowest stock price was $0.31 and its highest was $1.80 in the past 12 months.
What is Femasys’s market cap?
Femasys’s market cap is $26.34M.
When is Femasys’s upcoming earnings report date?
Femasys’s upcoming earnings report date is Nov 06, 2025 which is in 22 days.
How were Femasys’s earnings last quarter?
Femasys released its earnings results on Aug 08, 2025. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.163 by $0.003.
Is Femasys overvalued?
According to Wall Street analysts Femasys’s price is currently Undervalued.
Does Femasys pay dividends?
Femasys does not currently pay dividends.
What is Femasys’s EPS estimate?
Femasys’s EPS estimate is -0.12.
How many shares outstanding does Femasys have?
Femasys has 43,009,995 shares outstanding.
What happened to Femasys’s price movement after its last earnings report?
Femasys reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.163. Following the earnings report the stock price went down -12.36%.
Which hedge fund is a major shareholder of Femasys?
Currently, no hedge funds are holding shares in FEMY
Femasys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (937.74% Upside)
$5.50 (937.74% Upside)
Blogger Sentiment
Bullish
FEMY Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 14.0%
Last 30 Days ▲ 63.0%
Last 30 Days ▲ 63.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.19%
12-Months-Change
Fundamentals
Return on Equity
-329.45%
Trailing 12-Months
Asset Growth
-32.04%
Trailing 12-Months
Company Description
Femasys
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
FEMY Stock 12 Month Forecast
Average Price Target
$5.50
▲(937.74% Upside)
Technical Analysis
Harvard Bioscience
―
Retractable Technologies
―
Milestone Scientific
―
Predictive Oncology
―
Meihua International Medical Technologies Co., Ltd.
―
Ownership Overview
4.23% Insiders
2.72% Mutual Funds
7.51% Other Institutional Investors
83.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---